These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9763605)

  • 21. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
    Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
    Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
    Burdo TH; Gartner S; Mauger D; Wigdahl B
    J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD; Baglia LA; Curristin SM; Ruddell A
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
    Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
    J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages.
    Emori Y; Ikeda T; Ohashi T; Masuda T; Kurimoto T; Takei M; Kannagi M
    J Gen Virol; 2004 Sep; 85(Pt 9):2603-2613. PubMed ID: 15302954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
    Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
    J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.
    Henderson AJ; Calame KL
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8714-9. PubMed ID: 9238043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.
    Henderson AJ; Connor RI; Calame KL
    Immunity; 1996 Jul; 5(1):91-101. PubMed ID: 8758898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.
    Lee ES; Zhou H; Henderson AJ
    J Virol; 2001 Oct; 75(20):9703-12. PubMed ID: 11559803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis.
    Gold JA; Hoshino Y; Tanaka N; Rom WN; Raju B; Condos R; Weiden MD
    Infect Immun; 2004 Feb; 72(2):645-50. PubMed ID: 14742504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.
    Ravimohan S; Gama L; Engle EL; Zink MC; Clements JE
    PLoS One; 2012; 7(8):e42801. PubMed ID: 22952612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells.
    Lee ES; Sarma D; Zhou H; Henderson AJ
    Virology; 2002 Jul; 299(1):20-31. PubMed ID: 12167337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.
    Schwartz C; Catez P; Rohr O; Lecestre D; Aunis D; Schaeffer E
    J Virol; 2000 Jan; 74(1):65-73. PubMed ID: 10590092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.
    Coyle-Rink J; Sweet T; Abraham S; Sawaya B; Batuman O; Khalili K; Amini S
    Virology; 2002 Aug; 299(2):240-7. PubMed ID: 12202226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCAAT/enhancer-binding protein beta mediates interferon-gamma-induced p48 (ISGF3-gamma ) gene transcription in human monocytic cells.
    Xiao W; Wang L; Yang X; Chen T; Hodge D; Johnson PF; Farrar W
    J Biol Chem; 2001 Jun; 276(26):23275-81. PubMed ID: 11312260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
    Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
    Choy L; Derynck R
    J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.